BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38031335)

  • 1. Clinical characteristics, treatment, and outcome of low-risk non-HIV-associated cryptococcal meningitis: A retrospective cohort study.
    Liu J; Dong R; Zhang H; Yao S; Liu J; Yang L; Fan L; Su X; Wang A; Su Z; Ngai IK; Dai K; Jiang Y; Peng F
    Med Mycol; 2023 Dec; 61(12):. PubMed ID: 38031335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of cerebrospinal fluid white cell count during the prognostic assessment for cryptococcal meningitis patients: a retrospective study.
    Qu J; Jiang J; Lv X
    BMC Infect Dis; 2020 Aug; 20(1):571. PubMed ID: 32758162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
    Sloan D; Dlamini S; Paul N; Dedicoat M
    Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a machine learning model to predict prognosis in HIV-negative cryptococcal meningitis patients: a multicenter study.
    Liu J; Lu Y; Liu J; Liang J; Zhang Q; Li H; Zhong X; Bu H; Wang Z; Fan L; Liang P; Xie J; Wang Y; Gong J; Chen H; Dai Y; Yang L; Su X; Wang A; Xiong L; Xia H; Jiang Y; Liu Z; Peng F
    Eur J Clin Microbiol Infect Dis; 2023 Oct; 42(10):1183-1194. PubMed ID: 37606868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of Early Mycological Clearance in HIV-Negative Cryptococcal Meningitis.
    Su Z; Luo C; Dai K; Yuan D; Qin BE; Gu M; Liu J; Chen Y; Peng F; Jiang Y
    Open Forum Infect Dis; 2023 Apr; 10(4):ofad158. PubMed ID: 37035489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different presentations and outcomes between HIV-infected and HIV-uninfected patients with Cryptococcal meningitis.
    Liao CH; Chi CY; Wang YJ; Tseng SW; Chou CH; Ho CM; Lin PC; Ho MW; Wang JH
    J Microbiol Immunol Infect; 2012 Aug; 45(4):296-304. PubMed ID: 22608531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and treatment outcomes of human immunodeficiency virus-associated cryptococcal meningitis: a 2-year retrospective analysis.
    Song W; Shen YZ; Wang ZY; Qi TK; Liu L; Zhang RF; Wang JR; Tang Y; Chen J; Sun JJ; Lu HZ
    Chin Med J (Engl); 2020 Dec; 133(23):2787-2795. PubMed ID: 33273326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of clinical features and mortality of cryptococcal meningitis between patients with and without human immunodeficiency virus infection.
    Lee YC; Wang JT; Sun HY; Chen YC
    J Microbiol Immunol Infect; 2011 Oct; 44(5):338-45. PubMed ID: 21524972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of lenalidomide in HIV-associated cryptococcal meningitis patients with persistent intracranial inflammation: an open-label, single-arm, prospective interventional study.
    Wan Z; Tao R; Hui J; Liu X; Peng X; Guo Y; Zhu X; Huang Y; Zhu B
    J Neuroinflammation; 2023 Feb; 20(1):38. PubMed ID: 36793113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A preliminary study on the characteristics of Th1/Th2 immune response in cerebrospinal fluid of AIDS patients with cryptococcal meningitis.
    Li A; Zhu W; Yin J; Huang X; Sun L; Hua W; Wang W; Zhang T; Dai L; Wu H
    BMC Infect Dis; 2021 May; 21(1):500. PubMed ID: 34051748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes.
    Jarvis JN; Bicanic T; Loyse A; Namarika D; Jackson A; Nussbaum JC; Longley N; Muzoora C; Phulusa J; Taseera K; Kanyembe C; Wilson D; Hosseinipour MC; Brouwer AE; Limmathurotsakul D; White N; van der Horst C; Wood R; Meintjes G; Bradley J; Jaffar S; Harrison T
    Clin Infect Dis; 2014 Mar; 58(5):736-45. PubMed ID: 24319084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple therapy combined with ventriculoperitoneal shunts can improve neurological function and shorten hospitalization time in non-HIV cryptococcal meningitis patients with increased intracranial pressure.
    Li M; Liu J; Deng X; Gan Q; Wang Y; Xu X; Jiang Y; Peng F
    BMC Infect Dis; 2020 Nov; 20(1):844. PubMed ID: 33198666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptococcus neoformans ex vivo capsule size is associated with intracranial pressure and host immune response in HIV-associated cryptococcal meningitis.
    Robertson EJ; Najjuka G; Rolfes MA; Akampurira A; Jain N; Anantharanjit J; von Hohenberg M; Tassieri M; Carlsson A; Meya DB; Harrison TS; Fries BC; Boulware DR; Bicanic T
    J Infect Dis; 2014 Jan; 209(1):74-82. PubMed ID: 23945372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of Epstein-Barr virus in cerebrospinal fluid is associated with increased mortality in HIV-negative cryptococcal meningitis.
    Lu Y; Li S; Su Z; Luo C; Gu M; Yuan D; Qin BE; Dai K; Xia H; Chen Y; Peng F; Jiang Y
    Med Mycol; 2024 May; 62(5):. PubMed ID: 38710585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis.
    Loyse A; Wilson D; Meintjes G; Jarvis JN; Bicanic T; Bishop L; Rebe K; Williams A; Jaffar S; Bekker LG; Wood R; Harrison TS
    Clin Infect Dis; 2012 Jan; 54(1):121-8. PubMed ID: 22052885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple therapy versus amphotericin B plus flucytosine for the treatment of non-HIV- and non-transplant-associated cryptococcal meningitis: retrospective cohort study.
    Xu L; Liu J; Zhang Q; Li M; Liao J; Kuang W; Zhu C; Yi H; Peng F
    Neurol Res; 2018 May; 40(5):398-404. PubMed ID: 29560802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptococcal meningitis in Lilongwe and Blantyre, Malawi.
    Maher D; Mwandumba H
    J Infect; 1994 Jan; 28(1):59-64. PubMed ID: 8163834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of quantitative CSF microscopy to predict culture status and outcome in HIV-associated cryptococcal meningitis in a Brazilian cohort.
    Vidal JE; Gerhardt J; Peixoto de Miranda EJ; Dauar RF; Oliveira Filho GS; Penalva de Oliveira AC; Boulware DR
    Diagn Microbiol Infect Dis; 2012 May; 73(1):68-73. PubMed ID: 22578940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures.
    Bicanic T; Brouwer AE; Meintjes G; Rebe K; Limmathurotsakul D; Chierakul W; Teparrakkul P; Loyse A; White NJ; Wood R; Jaffar S; Harrison T
    AIDS; 2009 Mar; 23(6):701-6. PubMed ID: 19279443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing paradigm of cryptococcal meningitis: an eight-year experience from a tertiary hospital in South India.
    Abhilash KP; Mitra S; Arul JJ; Raj PM; Balaji V; Kannangai R; Thomas SA; Abraham OC
    Indian J Med Microbiol; 2015; 33(1):25-9. PubMed ID: 25559998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.